Ernesto Amato

Ernesto Amato

Auto-generated profile, based on publicly available information

Ernesto Amato

Department of Biomedical and Dental Sciences and of Morphofunctional Imaging, University of Messina, Messina, Italy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FGF. Guerriero
F. Guerriero
MFM. E. Ferrari
M. E. Ferrari
FBF. Botta
F. Botta
FFF. Fioroni
F. Fioroni
EGE. Grassi
E. Grassi
MCM. Cremonesi
M. Cremonesi
Kidney dosimetry in177Lu and90Y PRRT requires 3 to 6 whole-body/SPECT scans to extrapolate the peptide kinetics, and it is considered time and resource consuming. We investigated the most adequate timing for imaging and time-activity interpolating curve, as well as the performance of a simplified dosimetry, by means of just 1-2 scans. Finally the influence of risk factors and of the peptide (DOTATOC versus DOTATATE) is considered. 28 patients treated at first cycle with177Lu DOTATATE and 30 with177Lu DOTATOC underwent SPECT scans at 2 and 6 hours, 1, 2, and 3 days after the radiopharmaceutical injection. Dose was calculated with our simplified method, as well as the ones most used in the clinic, that is, trapezoids, monoexponential, and biexponential functions. The same was done skipping the 6 h and the 3 d points. We found that data should be collected until 100 h for177Lu therapy and 70 h for90Y therapy, otherwise the dose calculation is strongly influenced by the curve interpolating the data and should be carefully chosen. Risk factors (hypertension, diabetes) cause a rather statistically significant 20% increase in dose (t-test,P<0.10), with DOTATATE affecting an increase of 25% compared to DOTATOC (t-test,P<0.05).

10 February 2015 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
MPMassimiliano Pacilio
Massimiliano Pacilio
EAErnesto Amato
Ernesto Amato
NLNico Lanconelli
Nico Lanconelli
CBChiara Basile
Chiara Basile
LTLeonel Alberto Torres
Leonel Alberto Torres
MCMarta Cremonesi
Marta Cremonesi
This study compares 3D dose distributions obtained with voxel S values (VSVs) for soft tissue, calculated by several methods at their current state-of-the-art, varying the degree of image blurring. The methods were: 1) convolution of Dose Point Kernel (DPK) for water, using a scaling factor method; 2) an analytical model (AM), fitting the deposited energy as a function of the source-target distance; 3) a rescaling method (RSM) based on a set of high-resolution VSVs for each isotope; 4) local energy deposition (LED). VSVs calculated by direct Monte Carlo simulations were assumed as reference. Dose distributions were calculated considering spheroidal clusters with various sizes (251, 1237 and 4139 voxels of 3 mm size), uniformly filled with 131 I, 177 Lu, 188 Re or 90 Y. The activity distributions were blurred with Gaussian filters of various widths (6, 8 and 12 mm). Moreover, 3D-dosimetry was performed for 10 treatments with 90 Y derivatives. Cumulative Dose Volume Histograms (cDVHs) were compared, studying the differences in D 95% , D 50% or D max ( Δ D 95% , Δ D 50% and Δ D max ) and dose profiles. For unblurred spheroidal clusters, Δ D 95% , Δ D 50% and Δ D max were mostly within some percents, slightly higher for 177 Lu with DPK (8%) and RSM (12%) and considerably higher for LED ( Δ D 95% up to 59%). Increasing the blurring, differences decreased and also LED yielded very similar results, but D 95% and D 50% underestimations between 30–60% and 15–50%, respectively (with respect to 3D-dosimetry with unblurred distributions), were evidenced. Also for clinical images (affected by blurring as well), cDVHs differences for most methods were within few percents, except for slightly higher differences with LED, and almost systematic for dose profiles with DPK (−1.2%), AM (−3.0%) and RSM (4.5%), whereas showed an oscillating trend with LED. The major concern for 3D-dosimetry on clinical SPECT images is more strongly represented by image blurring than by differences among the VSVs calculation methods. For volume sizes about 2-fold the spatial resolution, D 95% and D 50% underestimations up to about 60 and 50% could result, so the usefulness of 3D-dosimetry is highly questionable for small tumors, unless adequate corrections for partial volume effects are adopted.

1 June 2013 in American Journal of Roentgenology
Verified
Journal Article
Closed access
EAErnesto Amato
Ernesto Amato
ISIgnazio Salamone
Ignazio Salamone
SNSerena Naso
Serena Naso
ABAntonio Bottari
Antonio Bottari
MGMichele Gaeta
Michele Gaeta
ABAlfredo Blandino
Alfredo Blandino
The purpose of this article is to quantify the CT radiation dose increment in five organs resulting from the administration of iodinated contrast medium.

1 October 2014 in Academic Radiology
Verified
Journal Article
Closed access
MGMichele Gaeta
Michele Gaeta
CBCaterina Benedetto
Caterina Benedetto
FMFabio Minutoli
Fabio Minutoli
TDTommaso D'Angelo
Tommaso D'Angelo
EAErnesto Amato
Ernesto Amato
SPStefano Pergolizzi
Stefano Pergolizzi

19 October 2012 in Medical Physics
Verified
Journal Article
Closed access
EAErnesto Amato
Ernesto Amato
FMFabio Minutoli
Fabio Minutoli
MPMassimiliano Pacilio
Massimiliano Pacilio
ACAlfredo Campennì
Alfredo Campennì
SBSergio Baldari
Sergio Baldari

22 July 2010 in Medical Physics
Verified
Journal Article
Closed access
EAErnesto Amato
Ernesto Amato
DLDomenico Lizio
Domenico Lizio
NSNicola Settineri
Nicola Settineri
APAndrea Di Pasquale
Andrea Di Pasquale
ISIgnazio Salamone
Ignazio Salamone
IPIgnazio Pandolfo
Ignazio Pandolfo